Mir-34A is a Microrna Safeguard for Citrobacter-induced Inflammatory Colon Oncogenesis.
Lihua Wang,Ergang Wang,Yi Wang,Robert Mines,Kun Xiang,Zhiguo Sun,Gaiting Zhou,Kai-Yuan Chen,Nikolai Rakhilin,Shanshan Chao,Gaoqi Ye,Zhenzhen Wu,Huiwen Yan,Hong Shen,Jeffrey Everitt,Pengcheng Bu,Xiling Shen
DOI: https://doi.org/10.7554/elife.39479
IF: 7.7
2018-01-01
eLife
Abstract:Inflammation often induces regeneration to repair the tissue damage. However, chronic inflammation can transform temporary hyperplasia into a fertile ground for tumorigenesis. Here, we demonstrate that the microRNA miR-34a acts as a central safeguard to protect the inflammatory stem cell niche and reparative regeneration. Although playing little role in regular homeostasis, miR-34a deficiency leads to colon tumorigenesis after Citrobacter rodentium infection. miR-34a targets both immune and epithelial cells to restrain inflammation-induced stem cell proliferation. miR-34a targets Interleukin six receptor (IL-6R) and Interleukin 23 receptor (IL-23R) to suppress T helper 17 (Th17) cell differentiation and expansion, targets chemokine CCL22 to hinder Th17 cell recruitment to the colon epithelium, and targets an orphan receptor Interleukin 17 receptor D (IL-17RD) to inhibit IL-17-induced stem cell proliferation. Our study highlights the importance of microRNAs in protecting the stem cell niche during inflammation despite their lack of function in regular tissue homeostasis.